precirol has been researched along with palmitic acid in 1 studies
| Studies (precirol) | Trials (precirol) | Recent Studies (post-2010) (precirol) | Studies (palmitic acid) | Trials (palmitic acid) | Recent Studies (post-2010) (palmitic acid) |
|---|---|---|---|---|---|
| 81 | 0 | 52 | 6,794 | 159 | 2,458 |
| Protein | Taxonomy | precirol (IC50) | palmitic acid (IC50) |
|---|---|---|---|
| Toll-like receptor 2 | Homo sapiens (human) | 5 | |
| Fatty acid-binding protein, intestinal | Homo sapiens (human) | 1.7 | |
| Fatty acid-binding protein, adipocyte | Homo sapiens (human) | 0.93 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 8.8 | |
| Fatty acid-binding protein 5 | Homo sapiens (human) | 1.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ko, YT; Ramalingam, P | 1 |
1 other study(ies) available for precirol and palmitic acid
| Article | Year |
|---|---|
Improved oral delivery of resveratrol from N-trimethyl chitosan-g-palmitic acid surface-modified solid lipid nanoparticles.
Topics: Administration, Oral; Animals; Biological Availability; Chitosan; Diglycerides; Drug Carriers; Drug Compounding; Drug Liberation; Fats; Hydrophobic and Hydrophilic Interactions; Kinetics; Male; Mice; Mice, Inbred BALB C; Nanoparticles; NIH 3T3 Cells; Oils; Palmitic Acid; Polysorbates; Resveratrol; Solubility; Stilbenes | 2016 |